References
- Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48
- Anabousi S, Laue M, Lehr CM, et al. (2005). Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. Eur J Pharm Biopharm 60:295–303
- Belletti D, Tonelli M, Forni F, et al. (2013). AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation. Colloids Surf A Physicochem Eng Asp 436:459–66
- Del Burgo LS, Hernández RM, Orive G, Pedraz JL. (2013). Nanotherapeutic approaches for brain cancer management. Nanomedicine-NBM 10:905–19
- Dong R, Yu LE. (2003). Investigation of surface changes of nanoparticles using TM-AFM phase imaging. Environ Sci Technol 37:2813–19
- Dubourg F, Aimè JP. (2000). Role of the adhesion between a nanotip and a soft material in tapping mode. Surf Sci 466:137–43
- Egerton RF. (2005). Physical principles of electron microscopy: an introduction to TEM, SEM, and AFM, 1st ed. New York: Springer
- Freger V, Gilron J, Belfer S. (2002). TFC polyamide membranes modified by grafting of hydrophilic polymers: an FT-IR/AFM/TEM study. J Memb Sci 209:283–92
- Gaidano G, Gloghini A, Gattei V, et al. (1997). Association of Kaposi’s Sarcoma-Associated Herpesvirus-Positive Primary Effusion Lymphoma with expression of the CD138/Syndecan-1 antigen. Blood 90:4894–900
- Koshkaryev A, Sawant R, Deshpande M, Torchilin V. (2013). Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv Drug Deliv Rev 65:24–35
- Lasic DD, Papahadjopoulos D. (1995). Liposomes revisited. Science 267:1275–6
- Lehner R, Wang X, Marsch S, Hunziker P. (2013). Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomedicine-NBM 9:742–57
- Luna M, Colchero I, Barò AM. (1998). Intermittent contact scanning force microscopy: the role of liquid necks. Appl Phys Lett 72:3461–3
- Marjan JM, Allen TM. (1996). Long circulating liposomes: past, present and future. Biotechnol Adv 14:151–75
- Mastrobattista E, Koning GA, Storm G. (1999). Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 40:103–27
- Meyer O, Kirpotin D, Hong K, et al. (1998). Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J Biol Chem 273:15621–7
- Moghimi SM, Szebeni J. (2003). Stealth LPs and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–78
- Nguyen T, Gu X, VanLandingham M, et al. (2001). Characterization of coating system interphases with phase imaging. AFM Proceedings of 24th Annual Meeting of the Adhesion Society; 2001; Blacksburg, VA, 68–70
- Pan X, Wu G, Yang W, et al. (2007). Synthesis of cetuximab-ILp via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem 18:101–8
- Ruozi B, Belletti D, Tombesi A, et al. (2011). AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study. Int J Nanomed 6:557–63
- Ruozi B, Riva G, Belletti D, et al. (2010). Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study. Nanomedicine 5:1051–64
- Ruozi B, Tosi G, Forni F, et al. (2005). Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes. Eur J Pharm Sci 25:81–9
- Ruozi B, Tosi G, Leo E, Vandelli MA. (2007). Application of atomic force microscopy to characterize liposomes as drug and gene carriers. Talanta 73:12–22
- Ruozi B, Tosi G, Tonelli M, et al. (2009). AFM phase imaging of soft-hydrated samples: a versatile tool to complete the chemical-physical study of liposomes. J Liposome Res 19:59–67
- Weiss B, Schneider M, Muys L, et al. (2007). Coupling of biotin-(poly(ethylene glycol))amine to poly(d, l-lactide-coglycolide) nanoparticles for versatile surface modification. Bioconjug Chem 18:1087–94
- Yadav SC, Kumari A, Yadav R. (2011). Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation. Peptides 32:173–87